Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
His published conclusion was that the compound should be treated as investigational
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer
These therapies are designed to enhance natural pulsatile hormone release while maintaining biological balance
LohmannSPoolMBFRozenbergKMKellerAKMoersCMldrupUet al
4 June 2015
US$ 27.62
US$ 28.80
US$ 26.07
US$ 27.47
US$ 22.51
US$ 20.45
US$ 24.20
US$ 27.95
US$ 28.68
US$ 29.47
